Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Tags Health & Science Social issues Eli Lilly and Co
From CNBC.com News
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Tags Companies Health & Science Biotechnology
From CNBC.com News
A world on weight loss drugs: How GLP-1s are reshaping the economy
Tags Pharmaceuticals Danone SA Economy
From CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Tags US: News Pfizer Inc Eli Lilly and Co
From CNBC.com News
FDA approves first-ever glucose monitoring system for weight loss from Signos
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Breaking News: Business
From CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Tags Viking Therapeutics Inc Breaking News: Business Health & Science
From CNBC.com News
Home Depot disappoints, Novo Nordisk's GLP-1 updates, an AI warning and more in Morning Squawk
Tags Target Corp Personnel Markets
From CNBC.com News
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Breaking News: Business
From CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
Tags Markets United Airlines Holdings Inc Dine Brands Global
From CNBC.com News
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
Tags Biotech and Pharmaceuticals Business Breaking News: Business
From CNBC.com News
Wegovy maker Novo Nordisk's sales hike in second quarter
Tags Europe News Markets Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Roche Holding AG
From CNBC.com News
Hims & Hers stock falls 10% on revenue miss
Tags Health care industry Media Internet
From CNBC.com News
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
Tags Mad Money elf Beauty Inc Investing
From CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
Tags Biotech and Pharmaceuticals Roche Holding AG Novo Nordisk A/S
From CNBC.com News
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Tags Biotech and Pharmaceuticals Breaking News: Business Novo Nordisk A/S
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags US: News Gilead Sciences Inc Zoetis Inc
From CNBC.com News
Shares of Novo Nordisk plunge 15% after Wegovy-maker cuts full-year guidance
Tags Europe News Earnings Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Researchers move closer to a universal cancer vaccine
Tags Biotech and Pharmaceuticals Teladoc Health Inc Moderna Inc
From CNBC.com News
Europe’s most valuable firm SAP flags U.S. trade slowdown but says Japan deal gives 'hope'
Tags SAP AG Breaking News: Markets LVMH Moet Hennessy Louis Vuitton SE
From CNBC.com News
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Breaking News: Business
From CNBC.com News
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health & Science
From CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Tags Business News Pharmaceuticals US: News
From CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Tags Johnson & Johnson Social issues Health & Science
From CNBC.com News
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Healthy Returns
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Politics Business Novo Nordisk A/S
From CNBC.com News
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Tags Hims & Hers Health Inc Health care industry Health & Science
From CNBC.com News
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Tags Healthy Returns Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Tags Health care industry Biotech and Pharmaceuticals Business
From CNBC.com News
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Tags Business News US: News Pharmaceuticals
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.